The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 ...

Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued ...

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

If you purchased Novo Nordisk securities during the Class Period you may be entitled to compensation without payment of any ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Long-Term Pick. In this article, we will summarize ...

The initiative was piloted at Boots pharmacies last year, but has now been taken to a national level, according to Novo Nordisk. "Up to 85% of the materials in every pen returned to Novo Nordisk ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other stocks. Ken Fisher is the founder and executive chairman of Fisher Asset Management ...

Trading in Novo Nordisk shares by board members, executives and associated persons Bagsværd, Denmark, 7 February 2025 — This company announcement discloses the data of the transaction(s ...

but Novo Nordisk is the first to make the technology available to NHS patients in the UK. Lilly is developing Tempo Smart Button, a device that attaches to its Tempo insulin delivery pen rang ...

In this video, I will go over Novo Nordisk's (NVO-3.62%) and Eli Lilly's recent earnings report. Watch the short video to learn more, consider subscribing, and click the special offer link below.